Skip to main content

Site Management Organization

Oncology Overview Highlights

  • 3,000+ patients enrolled per year across Sarah Cannon
  • 300+ first-in-human clinical trials conducted
  • Clinical trial leader in the majority of approved cancer therapies over the last 10 years
  • 3,000+ patients enrolled in immunotherapy trials to date

SMO Overview

Sarah Cannon’s Site Management Organization (SMO) offers operational, regulatory and other centralized research support services for sites on industry-sponsored and investigator-initiated trials. With access to a broad patient base, the SMO conducts and supports phase I through III and outcomes-based trials throughout its network of sites.

The SMO offers support services for trials across tumor types including complex GI, lung, breast/gynecologic, central nervous system, genitourinary, melanoma and blood cancers.

Centralized Support Services:

  • Program Development & Start-up
  • Contracting & Financial Services
  • Regulatory & Safety
  • Clinical Operations Support
  • Global Quality & Education
  • Technology Integration & Support

Our Differentiators:

  • Rapid Study Activation Timelines
  • Community Clinic-Based Model at Sarah Cannon Sites Provides Access to Larger Numbers of Patients
  • Efficiencies With Budget, Contract, and Informed Consent Negotiations
  • Utilization of Central IRBs
  • Standardized SOPs and Quality Metrics Across All Sarah Cannon Sites

SMO_Map